Tandem Diabetes Care, Inc. (TNDM) Free cash flow 2016–2025
Tandem Diabetes Care, Inc. (TNDM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.7MFY2025 · since FY2016: -$70.1M → -$29.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.7M | -694.1% |
| FY2024 | $5.0M | +108.5% |
| FY2023 | -$58.6M | -458.1% |
| FY2022 | $16.4M | -83.2% |
| FY2021 | $97.2M | +3648.0% |
| FY2020 | -$2.7M | -112.2% |
| FY2019 | $22.4M | +297.8% |
| FY2018 | -$11.3M | +84.3% |
| FY2017 | -$71.9M | -2.5% |
| FY2016 | -$70.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Net marginTNDM Gross profitTNDM Gross marginTNDM Operating incomeTNDM Operating marginTNDM Operating cash flowTNDM Capital expendituresTNDM Return on equityTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Total liabilitiesTNDM Shareholders’ equityTNDM overview →